Comparison of Varicella‐Zoster Virus–Specific Immunity of Patients with Diabetes Mellitus and Healthy Individuals
The Journal of Infectious Diseases2009Vol. 200(10), pp. 1606–1610
Citations Over TimeTop 17% of 2009 papers
Abstract
Cell-mediated immunity (CMI) has been shown to be critical for the prevention and control of varicella-zoster virus (VZV)-related diseases. Because a large population-based study has revealed that diabetes mellitus is a risk factor for herpes zoster, we studied VZV-specific immune responses of patients with diabetes mellitus and compared them with those of healthy individuals. In this study, we found that patients with diabetes mellitus had significantly lower CMI to VZV than did healthy individuals. These results suggest that the increased risk for herpes zoster among patients with diabetes mellitus may be related to decreased VZV-specific CMI.
Related Papers
- → Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19(2020)181 cited
- → Diabetes status affects long-term changes in coronal caries - The SHIP Study(2019)29 cited
- → Diabetes and life expectancy among Japanese – NIPPON DATA80(2012)19 cited
- Investigation and analysis on the status of diabetes cognition among COPD patients complicated with diabetes mellitus(2014)
- → FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH COVID-19 INFECTION(2023)